Radiotherapy-induced mucositis is breast-conserving cancer patients. Acute radiodermatitis, Localized skin eruption due to drugs and medicament
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Female patients diagnosed with breast tissue cancer Age over 18 years No concomitant chemotherapy No previous radiotherapy to the chest area Minimum radiation of 50 Gy during treatment BMI 20-30 Breast conserving surgery
Exclusion criteria
Exclusion criteria: Existence of underlying diseases hypersensitivity to Saffron petal Patients with metastatic carcinoma to the breast Inability of the patient to implement the treatment protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and severity of dermatitis. Timepoint: At the beginning of the study and every week for 6 weeks. Method of measurement: Physician evaluation checklist of incidence and severity of disease for the radiotherapy oncology group (RTOG). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning and the end of the study. Method of measurement: Ware & Sherbourne's quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences